BQ Prime’s special research section collates quality and in-depth equity and economy research reports from across India’s top brokerages, asset managers and research agencies. These reports offer BQ Prime’s subscribers an opportunity to expand their understanding of companies, sectors and the economy.
Nirmal Bang Report
Coromandel International Ltd.'s Q2 FY24 revenue came in at Rs 69.88 billion – 17.8%/17.1% below our/street estimates. At Rs 7.57 billion, profit after tax was a beat of 7.9%/3% versus our /street estimates. The nutrient segment’s revenue missed our estimate by 20.5%, offsetting the 8.7% beat in crop protection chemical revenue.
Coromandel International's Ebit margin in nutrient/CPC segment beat our estimates by 317 basis points/201 bps, resulting in a 1.2%/32.6% beat in nutrient/CPC segment Ebit.
The beat in consolidated PAT was aided by a beat of 3.2% in blended Ebit and 31% in other income while interest expense came in lower by 29.5%.
CPC business is facing global headwinds caused by persistent destocking and dumping by China.
Maintain 'Accumulate' post 1.8% cut in target price to Rs 1,059, valuing it at an unchanged price-to-earning of 14.25 times after rolling over to September-25E.
We expect healthy growth over FY23-FY26E despite the likely squeeze in H2 FY24E earnings.
Click on the attachment to read the full report:
DISCLAIMER
This report is authored by an external party. BQ Prime does not vouch for the accuracy of its contents nor is responsible for them in any way. The contents of this section do not constitute investment advice. For that you must always consult an expert based on your individual needs. The views expressed in the report are that of the author entity and do not represent the views of BQ Prime.
Users have no license to copy, modify, or distribute the content without permission of the Original Owner.
RECOMMENDED FOR YOU

Eternal Surpasses Titan, DMart in Market Cap; Now Bigger Than Wipro, Tata Motors


India Beat Higher-Ranked Oman In International Football For First Time


Paytm Gets Target Price Hike From Bernstein Over Strong EPS Outlook: "A Buy For Long Term"


HUL Q1 Results Review: Systematix Maintains 'Hold', Hikes Target Price — Here's Why
